ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1205

Real-time MRI for assessment of swallowing impairment in inclusion body myositis and oculopharyngeal muscular dystrophy.

Rachel Zeng1, Anke Rietveld2, Omar Al-Bourini1, Rosemarie HMJM Kroon2, Arno Olthoff1, Matthias Weidenmüller1, Per-Ole Carstens1, Isabel Kommerell1, Saskia G Schütz1, Corinne GC Horlings3, Johanna G Kalf3, Bert JM de Swart3, Baziel GM van Engelen2, Tim Friede1, Sabine Hofer1, Jens Frahm4, Ali Seif Amir Hosseini1, Jens Schmidt5 and Christiaan GJ Saris2, 1University Medical Center Göttingen, Göttingen, Germany, 2Radboudumc Research Institute for Medical Innovation, Nijmegen, Netherlands, 3Radboudumc Research Institute for Medical Innovation, Nijmegen, Germany, 4Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany, 5Immanuel University Hospital Rüdersdorf, Brandenburg Medical School, Rüdersdorf bei Berlin, Germany

Meeting: ACR Convergence 2025

Keywords: Imaging, Magnetic resonance imaging (MRI), Myositis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1191–1220) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Swallowing dysfunction -dysphagia- is a frequent and debilitating symptom in neuromuscular disorders, leading to malnutrition, cachexia, aspiration pneumonia and death. Identification of the underlying pathophysiological mechanisms is important for diagnosis and treatment. As standard assessments have limitations, novel imaging techniques are needed. In the present study, we investigated the utility of real-time MRI and quantitative muscle ultrasound for characterizing dysphagia in two different neuromuscular disorders.

Methods: This prospective cohort study included 18 patients with inclusion body myositis (IBM, 33% female, age 68.9 ± 7.7 years) and 13 with oculopharyngeal muscular dystrophy (OPMD, 62% female, age 55.9 ± 7.0 years) from two European Neuromuscular research centers (Nijmegen, NL; Göttingen, DE). Swallowing function was studied using real-time MRI (RT-MRI), FEES (flexible endoscopic evaluations of swallowing) and clinical assessments. T1-mapping and quantitative muscle ultrasound (QMUS) were used to analyze tissue properties in swallowing muscles. Outcomes were compared between the two muscle diseases. RT-MRI values were also compared to 22 age- and sex-matched non-myopathic controls.

Results: RT-MRI revealed significantly prolonged oral transit times in OPMD vs. controls (difference between means= 581.2 ms, 95% CI 225.9-936.4, p=0.002). Pharyngeal transit time was significantly prolonged in IBM vs. controls (difference between means= 1132.8 ms, 95% CI 482.2-1783, p=0.001). A cricopharyngeal bar as a well-established morphological indicator of dysphagia was identified in 80% patients with IBM compared to 53% in OPMD. Fatty degeneration of the tongue in OPMD significantly correlated between MRI-T1 values and ultrasound echogenicity (Spearman`s ρ= -0.52, p=0.005). ROC revealed excellent discrimination between diseases by combining RT-MRI, T1-mapping and QMUS (AUC= 0.95, 95% CI 0.86-1.00), while FEES and clinical assessments failed to differentiate specific patterns of dysphagia.

Conclusion: This study supports the value of novel MRI and ultrasound techniques for clinical use by identifying the pathophysiology and severity of impaired swallowing. Differentiating the phenotypes of dysphagia can aid in the diagnosis and treatment of affected patients.

Supporting image 1Figure 1. Quantitative muscle ultrasound (QMU) of orofacial muscles in IBM and OPMD patients.

Heatmap of echogenicity (A) and muscle thickness (B) obtained by QMU. I1-I18 are individual IBM patients, O1-O13 are individuals with OPMD. Color codes represent z-scores, with echogenicity z-scores between 1.5 and 2 considered borderline abnormal, z-scores ≥ 2 considered abnormal and z-scores > 3 considered as severely abnormal. Muscle thickness z-scores  -1.5 were considered abnormal. White represents missing data. (C) shows exemplary QMU findings of the tongue muscle. Echogenicity was analysed using histogram based grey-scale analysis and manually selected ROI, demarcated by the dotted green line (I), the dotted blue line delineates the border between the subcutaneous fat layer and muscle. Normal echogenicity of the tongue muscle in an IBM patient (II) and moderate signs of fibrosis and fatty infiltration in the tongue muscle of an OPMD patient (III).

Supporting image 2Figure 2. Real-time MRI assessment of swallowing in patients with IBM and OPMD versus control subjects.

A. RT-MRI at a resolution of 40 ms with exemplary findings in a control subject (upper row), an IBM patient (middle row) and an OPMD patient (bottom row). Images were selected at start of oral transit time (OTT) and subsequently 0.2 sec, 0.6 sec, 1.8 sec and 3.2 sec. Note how swallowing one bolus of pineapple juice (bright contrast, bolus head is marked by a green arrow) is completed in the control subject at 1.8 sec, while the IBM patient shows pharyngal retention and a cricopharyngeal bar at 1.8 sec and 3.2 sec. The OPMD patient shows a prolonged oral phase of swallowing until 1.8 sec after start of OTT, while the pharyngeal phase is unaffected and swallowing is completed by 3.2 sec. These RT-MRI sequences can be viewed in movie format in Supporting Information Movies S1 and S2.

B. RT-MRI shows a significantly prolonged OTT in patients with OPMD and to a lesser extent also in patients with IBM. The pharyngeal phases of swallowing (PTT and PCT) are significantly impaired in patients with IBM and in a few patients with OPMD. No differences between the cohorts were found for esophageal opening time (EOT). Hyoid-mental approximation (HMA) is significantly reduced in both diseases. No differences to controls were observed for relative laryngeal elevation (LAT). Variables were tested using t-tests and compared to a non-myopathic control group.

Supporting image 3Figure 3. T1 mapping of swallowing muscles in patients with IBM and OPMD versus control subject.

A. Selected T1 weighted MRI sequences (upper row) and T1 maps (middle and bottom row) obtained for head and neck region of a 71 y.o. control subject, a 64 y.o. IBM patient and a 61 y.o. OPMD patient. The bottom row outlines the manually placed regions of interest (dotted green lines) of the tongue muscles in the coronal sequences and the geniohyoid muscles in the sagittal sequences for analysis of mean T1 values.

B. T1 mapping reveal significantly lower T1 values of tongue muscle in OPMD patients indicating a higher fat content. T1 values of geniohyoid muscle and masseter muscle show no significant differences between patients and controls. Variables were tested using t-test.

C. The reduced T1 values of the tongue in quantitative MRI correlate significantly with increased echogenicity of the tongue on ultrasound in OPMD patients (Spearman r = -0,52; p = 0,005), both methods thereby indicating fibrosis and fatty infiltration of the tongue muscle.


Disclosures: R. Zeng: None; A. Rietveld: None; O. Al-Bourini: None; R. HMJM Kroon: None; A. Olthoff: None; M. Weidenmüller: None; P. Carstens: None; I. Kommerell: None; S. G Schütz: None; C. GC Horlings: None; J. Kalf: None; B. de Swart: None; B. van Engelen: None; T. Friede: None; S. Hofer: None; J. Frahm: None; A. Seif Amir Hosseini: None; J. Schmidt: None; C. Saris: None.

To cite this abstract in AMA style:

Zeng R, Rietveld A, Al-Bourini O, HMJM Kroon R, Olthoff A, Weidenmüller M, Carstens P, Kommerell I, G Schütz S, GC Horlings C, Kalf J, de Swart B, van Engelen B, Friede T, Hofer S, Frahm J, Seif Amir Hosseini A, Schmidt J, Saris C. Real-time MRI for assessment of swallowing impairment in inclusion body myositis and oculopharyngeal muscular dystrophy. [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/real-time-mri-for-assessment-of-swallowing-impairment-in-inclusion-body-myositis-and-oculopharyngeal-muscular-dystrophy/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/real-time-mri-for-assessment-of-swallowing-impairment-in-inclusion-body-myositis-and-oculopharyngeal-muscular-dystrophy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology